Disagree
Home Balkan Pharmaceuticals Balkan Pharmaceuticals
Esculap 20
Esculap 20 - Balkan Pharmaceuticals

Esculap 20 - Balkan Pharmaceuticals

Brand:
Category:
Substance:
Dosage:
20 mg/tab
Package:
5 tablets, 60 tablets
Price:
$30.00 - $90.00
See options
Product Overview

Tadalafil, or Cialis, is known for its impressive, extended duration, providing up to 36 hours of efficacy for erectile dysfunction treatment. This flexibility sets tadalafil apart from other ED solutions by allowing users a more spontaneous approach. It functions by inhibiting the PDE5 enzyme, which increases blood flow to specific areas upon arousal. Gaining FDA approval in 2003, tadalafil is appreciated for its versatility, suitable for either daily administration or as-needed use. Its reliable, long-acting benefits continue to make it a top choice for ED management worldwide.

References:

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Esculap 20 by Balkan Pharmaceuticals, consult with your doctor or healthcare professional.

Products
Show more
Explore More Products
FAQ
Why did Cialis stand out in clinical trials?
Clinical trials highlighted its long duration, making it favorable compared to shorter-acting treatments.
References:

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.

What sets the pharmacological profile of Cialis apart?
Its unique β-carboline-type structure provides a prolonged effect, unmatched by other PDE5 inhibitors.
References:

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.

How do Cialis and vardenafil differ in action?
Cialis lasts longer than vardenafil, which has a similar duration to sildenafil.
References:

Coward, R.M. & Carson, C.C., 2008. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management.